2,246 results on '"Willerson, James T."'
Search Results
52. Single Nucleotide Polymorphisms in Cholesteryl Ester Transfer Protein Gene and Recurrent Coronary Heart Disease or Mortality in Patients With Established Atherosclerosis
53. Inflammation and Cardiovascular Disease
54. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder
55. CD133+ Stem Cells in the Treatment of Patients With Refractory Angina
56. The Athena trials: Autologous adipose‐derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction
57. Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors
58. List of Contributors
59. Regenerative Medicine and the Cardiovascular System: A Good Start**Modified from a manuscript published in Circulation Research 2014;115(12);271–78.
60. Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials
61. Mechanisms contributing to the abrupt conversion from stable to unstable angina and myocardial infarction
62. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)
63. Usefulness of Single Nucleotide Polymorphism in Chromosome 4q25 to Predict In-Hospital and Long-Term Development of Atrial Fibrillation and Survival in Patients Undergoing Coronary Artery Bypass Grafting
64. Antiplatelet Agents
65. Platelets, Platelet Mediators, and Unstable Coronary Artery Disease Syndromes
66. Cyclic flow alterations and neointimal proliferation following experimental coronary stenosis and endothelial injury
67. Medical Treatment of Unstable Angina and Acute Non-ST-Elevation Myocardial Infarction
68. Medical Treatment of Stable Angina
69. Treatment of Acute ST-Elevation Myocardial Infarction
70. Coronary Heart Disease Syndromes: Pathophysiology and Clinical Recognition
71. Clinical Use of Serum Biomarkers in the Prediction of Cardiovascular Risk
72. Specific Platelet Mediators and the Abrupt Progression of Coronary Artery Stenoses : Experimental Evidence and Potential Clinical Implications
73. Gadonanotubes as magnetic nanolabels for stem cell detection
74. Difference in Patient Profiles and Outcomes in Japanese Versus American Patients Undergoing Coronary Revascularization (Collaborative Study by CREDO-Kyoto and the Texas Heart Institute Research Database)
75. Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial
76. Changing of the guard?
77. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
78. Imaging of Hepatic Low Density Lipoprotein Receptors by Radionuclide Scintiscanning in vivo
79. Radioimmunoassay of Creatine Kinase-B Isoenzyme in Human Sera: Results in Patients with Acute Myocardial Infarction
80. Frequency and Severity of Cyclic Flow Alternations and Platelet Aggregation Predict the Severity of Neointimal Proliferation Following Experimental Coronary Stenosis and Endothelial Injury
81. Localization of Anti-Mitochondrial Antibody in Experimental Canine Myocardial Infarcts
82. Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial
83. Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction
84. Development of a Network to Test Strategies in Cardiovascular Cell Delivery: The NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN)
85. One-Year Follow-up of Intracoronary Stem Cell Delivery on Left Ventricular Function Following ST-Elevation Myocardial Infarction
86. A randomized trial of rosuvastatin in the prevention of venous thromboembolism
87. The use of high-sensitivity assays for C-reactive protein in clinical practice
88. Adult stem cells: Early clinical trials and perspective
89. Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies
90. Suppressing Hippo signaling in the stem cell niche promotes skeletal muscle regeneration
91. The Next Big Step for the Texas Heart Institute Journal
92. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
93. Coronary thermography for detection of vulnerable plaques
94. Three-Dimensional Isotropic Wavelets for Post-Acquisitional Extraction of Latent Images of Atherosclerotic Plaque Components from Micro-Computed Tomography of Human Coronary Arteries
95. Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
96. Suppression of canonical Wnt/[beta]-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy
97. A Phase I Study of Allogeneic Mesenchymal Stem Cell Therapy in Patients with Heart Failure Secondary to Anthracycline-induced Cardiomyopathy: The Cctrn Stem Cell Injection in Cancer Survivors (Seneca) Trial
98. Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes
99. In Memoriam: John Timothy Bricker (1952–2013)
100. Congratulations to THIʼs Professional Staff and Employees
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.